Increase of phosphatase and tensin homolog by silymarin to inhibit human pharynx squamous cancer

Journal of Medicinal Food

Volumn 16, Issue 9, 2013, Pages 778-784

  Su, Chin Hui ^a,b,c   Chen, Li Jen ^d   Liao, Jyh Fei ^a   Cheng, Juei Tang ^d,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Akt signaling; Bad; Bcl 2; FaDu cells; PTEN; Silymarin

Indexed keywords

CASPASE 3; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE B; SILIBININ; SILYMARIN; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUTH CANCER; PHARYNX CANCER; PHARYNX SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; MILK THISTLE; PHARYNGEAL NEOPLASMS; PHOSPHORYLATION; PLANT EXTRACTS; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; SILYMARIN;

EID: 84884525706     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2534     Document Type: Article

References (41)

1. Kroll DJ, Shaw HS, Oberlies NH: Milk thistle nomenclature: Why it matters in cancer research and pharmacokinetic studies. Integr Cancer Ther 2007;6:110-119
2. Feher J, Lengyel G: [Silymarin in the treatment of chronic liver diseases: Past and future]. Orv Hetil 2008;149:2413-2418
3. Saller R, Meier R, Brignoli R: The use of silymarin in the treatment of liver diseases. Drugs 2001;61:2035-2063
4. Flora K, Hahn M, Rosen H, Benner K: Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 1998;93:139-143
5. Ramasamy K, Agarwal R: Multitargeted therapy of cancer by silymarin. Cancer Lett 2008;269:352-362
6. Peyrou M, Bourgoin L, Foti M: PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer. Dig Dis 2010; 28:236-246
7. Singh RP, Agarwal R: A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer. Mutat Res 2004;555:21-32
8. Jacobs BP, Dennehy C, Ramirez G, Sapp J, Lawrence VA: Milk thistle for the treatment of liver disease: A systematic review and meta-analysis. Am J Med 2002;113:506-515
9. Lieber CS, Leo MA, Cao Q, Ren C, DeCarli LM: Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol 2003;37:336-339
10. Bold RJ, Termuhlen PM, McConkey DJ: Apoptosis, cancer and cancer therapy. Surg Oncol 1997;6:133-142
11. Yoon Y, Kim YO, Jeon WK, Park HJ, Sung HJ: Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line. J Ethnopharmacol 1999;68:121-127
12. Seo WG, Pae HO, Oh GS, et al.: Ethyl acetate extract of the stem bark of Cudrania tricuspidata induces apoptosis in human leukemia HL-60 cells. Am J Chin Med 2001;29:313-320
13. Lien HM, Lin HW, Wang YJ, et al.: Inhibition of anchorageindependent proliferation and G0/G1 cell-cycle regulation in human colorectal carcinoma cells by 4,7-dimethoxy-5-methyll, 3-benzodioxole isolated from the fruiting body of Antrodia camphorate. Evid Based Complement Alternat Med 2011 [Epub ahead of print]; DOI:10.1093/ecam/nep020
14. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C: PI3K/ Akt and apoptosis: Size matters. Oncogene 2003;22:8983-8998
15. Franke TF, Yang SI, Chan TO, et al.: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995;81:727-736
16. Franke TF, Cantley LC: Apoptosis. A Bad kinase makes good. Nature 1997;390:116-117
17. Cantley LC, Neel BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 1999; 96:4240-4245
18. Kurose K, Zhou XP, Araki T, Cannistra SA, Maher ER, Eng C: Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol 2001;158:2097-2106
19. Chung JH, Eng C: Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res 2005;65:8096-8100
20. Parsons R: Human cancer, PTEN and the PI-3 kinase pathway. Semin Cell Dev Biol 2004;15:171-176
21. Workman P, Clarke PA, Raynaud FI, van Montfort RL: Drugging the PI3 kinome: From chemical tools to drugs in the clinic. Cancer Res 2010;70:2146-2157
22. Varghese L, Agarwal C, Tyagi A, Singh RP, Agarwal R: Silibinin efficacy against human hepatocellular carcinoma. Clin Cancer Res 2005;11:8441-8448
23. Lah JJ, Cui W, Hu KQ: Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007;13: 5299-5305
24. Cui W, Gu F, Hu KQ: Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol 2009;15:1943-1950
25. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK: Head and neck cancer. N Engl J Med 1993;328:184-194
26. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31
27. Chen PN, Hsieh YS, Chiang CL, Chiou HL, Yang SF, Chu SC: Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J Dent Res 2006;85:220-225
28. Yu HC, Chen LJ, Cheng KC, Li YX, Yeh CH, Cheng JT: Silymarin inhibits cervical cancer cell through an increase of phosphatase and tensin homolog. Phytother Res 2012;26:709-715
29. Scudiero DA, Shoemaker RH, Paull KD, et al.: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988;48:4827-4833
30. Matsuda T, Ferreri K, Todorov I, et al.: Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: Implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways. Endocrinology 2005;146:175-185
31. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010;465:1033-1038
32. Salvesen GS, Dixit VM: Caspases: Intracellular signaling by proteolysis. Cell 1997;91:443-446
33. Agarwal C, Singh RP, Dhanalakshmi S, et al.: Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 2003;22:8271-8282
34. Nukatsuka M, Saito H, Sakamoto K, et al.: Efficacy of combination chemotherapy using oral fluoropyrimidine S-1 with oxaliplatin (SOX) against colorectal cancer in vivo. Anticancer Res 2012;32:2807-2812
35. Lu Y, Lin YZ, LaPushin R, et al.: The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 1999;18: 7034-7045
36. Kanamori Y, Kigawa J, Itamochi H, et al.: Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clin Cancer Res 2001;7:892-895
37. Palomero T, Dominguez M, Ferrando AA: The role of the PTEN/ AKT Pathway in NOTCH1-induced leukemia. Cell Cycle 2008; 7:965-970
38. Zhong X, Zhu Y, Lu Q, Zhang J, Ge Z, Zheng S: Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway. Toxicology 2006;227:211-216
39. Katiyar SK, Roy AM, Baliga MS: Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/ Bax, cytochrome c release, and caspase activation. Mol Cancer Ther 2005;4:207-216
40. Kaur M, Velmurugan B, Tyagi A, Agarwal C, Singh RP, Agarwal R: Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through downregulation of beta-catenin-dependent signaling. Neoplasia 2010; 12:415-424
41. Deep G, Oberlies NH, Kroll DJ, Agarwal R: Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells. Int J Cancer 2008;123:41-50